End Gas Station Heroin Legislation by Sen. Moreno Analyzed
Bailey Malota
WASHINGTON, Aug. 31 -- The End Gas Station Heroin Act, originally introduced by Sen. Bernie Moreno, R-Ohio, on August 8, 2026, has been analyzed by the Congressional Research Service. The bill seeks to amend the Controlled Substances Act to classify MGM-15 and MGM-16 as Schedule I controlled substances, as well as to schedule synthetic 7-hydroxymitragynine and Mitragynine Pseudoindoxyl, thereby enhancing regulatory measures on these emerging synthetic opioids.
Motivated by the escalating opioid crisis, the proposed legislation aims to combat the rapid influx of powerful synthetic opioids, often
... Show Full Article
WASHINGTON, Aug. 31 -- The End Gas Station Heroin Act, originally introduced by Sen. Bernie Moreno, R-Ohio, on August 8, 2026, has been analyzed by the Congressional Research Service. The bill seeks to amend the Controlled Substances Act to classify MGM-15 and MGM-16 as Schedule I controlled substances, as well as to schedule synthetic 7-hydroxymitragynine and Mitragynine Pseudoindoxyl, thereby enhancing regulatory measures on these emerging synthetic opioids.
Motivated by the escalating opioid crisis, the proposed legislation aims to combat the rapid influx of powerful synthetic opioids, oftenreferred to as gas station heroin, which pose serious health risks and are increasingly associated with overdose deaths. By bringing these substances under stricter regulation, the bill intends to provide law enforcement agencies with greater tools to restrict manufacture, distribution, and access to these harmful drugs.
The bill establishes specific thresholds for the allowable concentration of these synthetic opioids in certain products, ensuring that naturally occurring mitigated forms found in kratom remain exempted provided they adhere to these limits. This nuanced approach acknowledges the contrasting use of kratom while tightening it against synthetic variants that are synthesized and produced artificially.
Furthermore, the legislation outlines enhanced enforcement actions against opioid manufacturers and distributors involved in the commercial distribution of these substances. This includes civil and criminal penalties aimed at those knowingly participating in such illegal activities, while also clarifying that individuals using these substances for personal consumption will not face criminal liability.
As lawmakers continue to address the multifaceted challenges presented by the opioid epidemic, Sen. Moreno's bill represents a significant step towards more stringent regulation and enforcement surrounding synthetic opioids, signifying a push for a safer public health landscape.
The bill is S. 5383.
* * # * *
Primary source of information: https://www.congress.gov/bill/119th-congress/senate-bill/5383/text
